- News Home
10 April 2014 11:44 am ,
Vol. 344 ,
Balkan endemic kidney disease surfaced in the 1950s and for decades defied attempts to finger the cause. It occurred...
The Pyrenean ibex, an impressive mountain goat that lived in the central Pyrenees in Spain, went extinct in 2000. But a...
Tight budgets are forcing NASA to consider turning off one or more planetary science projects that have completed their...
Ebola is not a stranger to West Africa—an outbreak in the 1990s killed chimpanzees and sickened one researcher. But the...
In an as-yet-unpublished report, an international panel of geoscientists has concluded that a pair of deadly...
Tropical disease experts tried and failed before to eradicate yaws, a rare disfiguring disease of poor countries. Now,...
Since 2002, researchers have reported that agricultural communities in the hot and humid Pacific Coast of Central...
- 10 April 2014 11:44 am , Vol. 344 , #6180
- About Us
E.U. Science Panel Dismisses French GM Concerns--Again
22 May 2012 1:33 pm
France's latest attempt to keep genetically modified (GM) crops from its fields has been rebuked by a scientific panel at the European Food Safety Authority (EFSA). Yesterday, EFSA issued an opinion dismissing France's argument that a GM maize variety produced by Monsanto might be harmful to the environment or human health.
The opinion is the latest blow in a long-running battle over MON810, also known as YieldGard, whose cultivation has been banned in a handful of European countries despite its approval by the European Commission in 1998. The French government, faced with strong public opposition to GM crops, banned Mon810 in 2008 under a so-called "safeguard clause" that gives countries some leeway to duck European rules. EFSA rejected the measure later that year, and in 2011, France's Council of State also ruled that the prohibition was out of line.
In February, France again asked the European Commission for permission to ban MON810, armed with a new scientific dossier. In it, the French government argues, among other things, that Cry1Ab, a protein produced by MON810 to ward off maize stalk borers, could hurt non-target species such as bees and butterflies, and that it could linger in the soil. But in yesterday's report, EFSA's Panel on Genetically Modified Organisms said the file contains some of the same evidence France presented—and EFSA rejected—in 2008; in the remainder, the panel "could not identify any new science-based evidence indicating that maize MON 810 cultivation in the EU poses a significant and imminent risk to the human and animal health or the environment."
Given recent history, EFSA's decision is "not really a surprise," AFP quoted a spokesperson for European health Commissioner John Dalli as saying. The commission is considering its next move, but "technically, we could now demand that France lift its ban," the spokesperson said.